Tissue transglutaminase (EC 2.3.2.13) is a calcium-activated enzyme th
at cross-links specific substrate proteins into insoluble, protease-re
sistant, high molecular weight complexes. Because the neurofibrillary
tangles in Alzheimer disease have similar biochemical characteristics,
and because the microtubule-associated protein tau is the predominant
component of these structures, the substrate properties of tau with r
espect to transglutaminase were investigated. Bovine tau and recombina
nt human tau isoforms rapidly form high molecular weight, cross-linked
polymers on incubation with transglutaminase. Polyamine incorporation
assays indicate that bovine tau is an excellent substrate of transglu
taminase, with a K-m of 10.4 +/- 2.2 mu M and a V-max of 40.9 +/- 4.5
nmol/mg of enzyme/ min. Individual recombinant human tau isoforms are
not equivalent with respect to transglutaminase, as the smallest isofo
rm T3 (352 amino acids) is not as good a substrate as the larger isofo
rms T4 (383 amino acids) and T4L (441 amino acids). To determine which
segments of the tau protein are susceptible to modification by transg
lutaminase, tau was labeled with [H-3]putrescine by transglutaminase a
nd proteolyzed with ar-chymotrypsin, and the breakdown products were a
nalyzed. These experiments demonstrate that the enzyme modifies tau at
only one or a few discrete sites, primarily in the carboxyl half of t
he molecule. Thus, the reaction is specific for only a small number of
the many glutamine residues in tau. Furthermore, a tau deletion const
ruct (T264) containing a portion of the microtubule-binding domains, w
hich is a substrate of transglutaminase, cannot be cross-linked by the
enzyme. This provides evidence that the cross-linking reaction is spe
cific, and requires that the substrates be appropriately associated fo
r cross-linking to occur.